Abstract
The foramen ovale (FO) is the structure responsible for maintaining the fetal circulation while the lung is still not functioning. The blood passes from the mother to the fetus through the umbilical cord, ascends to the right atrium, and, through the FO, reaches the left atrium, thus nourishing the left side of the heart. Shortly after birth, FO closes; however, approximately 25% of adults have the patent foramen ovale (PFO). The main clinical implications are stroke, migraine, platypnea-orthodeoxia, obstructive sleep apnea, surgical risk for large surgeries, and persistent cyanosis. The method of choice for diagnosis is transesophageal echocardiography (TEE) sensitized by injection of saline solution with microbubbles at the end of the sustained Valsalva maneuver. The available therapeutic approaches consist of the drug treatment (antiplatelet and anticoagulant drugs) in the surgical or percutaneous closure. We report a case of female patient, 39 years old, with a complaint of migraine with aura, debilitating and refractory to medications since her childhood, and dyspnea on average efforts for 5 years, with no other concomitant symptoms. At 27, she suffered a stroke with no thrombogenic focus found, which left no sequelae. During a cardiological investigation, a TEE was performed and PFO was visualized. From this, endovascular treatment with occlusion device was chosen because it is highly recommended for percutaneous closure of PFO with a history of stroke without an identifiable cause and evidence of right-to-left shunt identified by TEE in patients less than 55 years. In the sixth month after the procedure, a new TEE was performed, which revealed preserved left ventricular global systolic function and normal relaxation, without detectable residual shunt, in addition to the patient reporting complete remission of migraine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Chamié F, Chamié D, Ramos S, Tress JC, Victer R. Patent foramen ovale percutaneous closure. Braz J Cardiol Invasive. 2005;3:185–97.
Miranda M. Patent foramen ovale and ischemic stroke. 2016. Available at: www.ineuro.com.br/para-os-pacientes/forame-oval-patente-e-avc-isquemico/ (Accessed at 8 Aug 2016).
Nercolini D, Guérios EE, Selig FA. Questions about congenital heart defects. Center of Congenital and Structural Heart Diseases of Paraná website; 2010. Available at: www.centroconcept.com.br/faq1.php (Accessed at 8 Aug 2016).
Chamié FJA. Indications of patent foramen ovale closure. Paper presented at the annual course of revision in hemodynamic and interventional cardiology by Brazilian Society of Hemodynamics and Interventional Cardiology, November 5–6, São Paulo – BR; 2010.
Eggers AE. A new theory of cryptogenic stroke and its relationship to patent foramen ovale; or, the puzzle of the missing extra risk. Med Hypotheses J. 2006;67:1072–5.
Vigna C. Improvement of migraine after patent foramen ovale percutaneous closure in patients with subclinical brain lesions: a case-control study. J Am Coll Cardiol Intv. 2009;2:107–13.
Fukujima MM, Tatani SB, Prado GF. Patent foramen ovale and stroke – current trends. Neurosci Mag. 2004;12(4):209–11.
Abizaid A, Júnior JRC. Interventional cardiology guide of Dante Pazzanese Institute. 1st ed. Rio de Janeiro: Elsevier; 2013. p. 470–7.
Lavinsky M, Wolff FH, Polanczyk CA, Rohde LEP, Pagnoncelli A, Maulaz A. Summary of evidence and recommendations for percutaneous closure of patent foramen ovale in the secondary prevention of cerebrovascular events. 2007. Available at: www.unimed.coop.br/pct/servlet/ServletDownload?id=MjE0NzUxMTExMA== (Accessed at 28 Aug 2016).
Sabaté M. Percutaneous cardiac interventions – tips and tricks of new techniques beyond stenting. Toulouse: Europa Edition; 2010. p. 151–4.
Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, Lipscombe SL, Rees T, De Giovanni JV, Morrison WL, Hildick-Smith D, Elrington G, Hillis WS, Malik IS, Rickards A. Migraine Intervention With STARFlex Technology (MIST) Trial: A Prospective, Multicenter, Double-Blind, Sham-Controlled Trial to Evaluate the Effectiveness of Patent Foramen Ovale Closure With STARFlex Septal Repair Implant to Resolve Refractory Migraine Headache. Circulation. 2008;117(11):1397–404.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Flores, L.G., Tomazoni, C., Freitag, P., Flores, E.L.Q., Almeida, R.M.S. (2019). Percutaneous Occlusion of a Patent Foramen Ovale. In: Almeida, R., Jatene, F. (eds) Cardiovascular Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-57084-6_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-57084-6_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-57083-9
Online ISBN: 978-3-319-57084-6
eBook Packages: MedicineMedicine (R0)